Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.45 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 2/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | GGT1 | P19440 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8254457 | 1.00 | FOLH1 (0.45) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL29741342 | 0.94 | FOLH1 (0.51) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL787393 | 0.94 | FOLH1 (0.51) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL1116199 | 0.94 | FOLH1 (0.51) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL7027611 | 0.86 | FOLH1 (0.46) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL7027613 | 0.86 | FOLH1 (0.46) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL3725106 | 0.86 | FOLH1 (0.46) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL4783069 | 0.85 | FOLH1 (0.45) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL4783065 | 0.85 | FOLH1 (0.45) | FOLH1GABRR1CPB2GSRSLC6A5 | |
| SCHEMBL9810181 | 0.83 | ACE (0.43) | FOLH1CPB2ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9434924-B2 | Cell culture method and cell culture kit | NIPRO CORPORATION (JP) | 2016-09-06 | — | — | US | claimed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-11060079-B2 | Methods and microorganisms for producing flavors and fragrance chemicals | ARDRA INC. (CA) | 2021-07-13 | — | — | US | disclosed |
| US-20190177713-A1 | METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS | ARDRA INC. (CA) | 2019-06-13 | — | — | US | disclosed |
| EP-2700707-B1 | CELL CULTURE METHOD AND CELL CULTURE KIT | NIPRO CORP (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-20140087465-A1 | CELL CULTURE METHOD AND CELL CULTURE KIT | NIPRO CORPORATION (JP) | 2014-03-27 | — | — | US | disclosed |
| EP-2700707-A1 | CELL CULTURE METHOD AND CELL CULTURE KIT | Nipro Corporation (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-7045532-B2 | ACE-2 modulating compounds and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2006-05-16 | — | — | US | disclosed |
| US-6632830-B1 | Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder | MILLENNIUM PHARMACEUTICALS, INC. | 2003-10-14 | — | — | US | disclosed |